Multiplex Assays Market Set to Reach USD 10.65 Billion by 2031 Amid Rising Demand for Advanced Diagnostics
The global healthcare landscape is undergoing a significant transformation driven by the increasing need for rapid, accurate, and high-throughput diagnostic solutions. Among the technologies gaining considerable momentum are multiplex assays, which enable the simultaneous detection and analysis of multiple biomarkers from a single sample. According to recent market research, the global multiplex assays market is projected to grow from USD 7.15 billion in 2026 to USD 10.65 billion by 2031, registering a CAGR of 8.3% during the forecast period . The market’s expansion is being fueled by rising incidences of infectious diseases, cancer, and autoimmune disorders, coupled with growing investments in precision medicine and advanced diagnostic technologies. As healthcare systems increasingly prioritize early disease detection and personalized treatment approaches, multiplex assays are emerging as indispensable tools across research and clinical settings. Download PDF Brochure Growing ...